Tern Therapeutics

Tern Therapeutics develops transformative, one-time genetic treatments for rare diseases.

Company Details

Founded: 2023
Employees: Between 2 - 10 employees
Raised: $15,000,000
Public: No
Acquired: No
CEO: Alex M. Bailey, Ph.D.
Founders: Alex M. Bailey, Ph.D.
Christina M. Ohnsman
Matthew Rosini

Company Collections

These are collections Tern Therapeutics is a part of. Click on the collection name to view similar companies.

Tern Therapeutics' Industries

Medical Organizations

Biotechnology Companies